15-44711166-T-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001387263.1(PATL2):​c.-400A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PATL2
NM_001387263.1 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.14

Publications

16 publications found
Variant links:
Genes affected
PATL2 (HGNC:33630): (PAT1 homolog 2) Predicted to enable RNA binding activity. Predicted to be involved in P-body assembly and deadenylation-dependent decapping of nuclear-transcribed mRNA. Predicted to act upstream of or within negative regulation of cytoplasmic mRNA processing body assembly. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
B2M (HGNC:914): (beta-2-microglobulin) This gene encodes a serum protein found in association with the major histocompatibility complex (MHC) class I heavy chain on the surface of nearly all nucleated cells. The protein has a predominantly beta-pleated sheet structure that can form amyloid fibrils in some pathological conditions. The encoded antimicrobial protein displays antibacterial activity in amniotic fluid. A mutation in this gene has been shown to result in hypercatabolic hypoproteinemia.[provided by RefSeq, Aug 2014]
B2M Gene-Disease associations (from GenCC):
  • hypoproteinemia, hypercatabolic
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • variant ABeta2M amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • MHC class I deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial visceral amyloidosis
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PATL2NM_001387263.1 linkc.-400A>G 5_prime_UTR_variant Exon 1 of 18 ENST00000682850.1 NP_001374192.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PATL2ENST00000682850.1 linkc.-400A>G 5_prime_UTR_variant Exon 1 of 18 NM_001387263.1 ENSP00000508024.1
PATL2ENST00000558573.1 linkn.151A>G non_coding_transcript_exon_variant Exon 1 of 2 2
B2MENST00000695792.1 linkn.-192T>C upstream_gene_variant

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
258394
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
136348
African (AFR)
AF:
0.00
AC:
0
AN:
8224
American (AMR)
AF:
0.00
AC:
0
AN:
12272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
7808
East Asian (EAS)
AF:
0.00
AC:
0
AN:
14724
South Asian (SAS)
AF:
0.00
AC:
0
AN:
36484
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
12830
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1098
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
150230
Other (OTH)
AF:
0.00
AC:
0
AN:
14724
GnomAD4 genome
Cov.:
30

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
3.4
DANN
Benign
0.69
PhyloP100
-1.1
PromoterAI
0.0096
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2255235; hg19: chr15-45003364; API